In a decree, IRCS President appointed Dr. Hassan Saffarieh as MPO's Managing Director
Citing from
IRCS website and reported by MPO's public relations and international affairs,
Dr. Hemmati's letter of appointment reads
as follows:
According to the
first clause of the act approved at the 259 session of Board meeting dated 21
Sep 2019 and by virtue of your commitment and valuable experiences, you are
appointed as MPO's Managing Director.
You are
expected to develop discipline, establish productivity, work hard, improve planning
and monitoring, moving towards development and growth of subsidiary companies, remove
barriers in the way of production and rendering pharmaceutical services,
establish empathy and cooperation among subsidiary companies, expand human
resources' efficiency, perform assigned tasks by MPO's General Assembly in a
precise and timely manner.